The safety and effectiveness of Bivigam in pediatric patients 2 years of age and older was based on data from 2 prospective, open-label, single-arm, studies. The Food and Drug Administration (FDA) has ...

Tokyo Medical and Dental University (TMDU) researchers have discovered that patients with 18q deletion syndrome can experience both cellular and humoral immunodeficiency Tokyo, Japan – Chromosome 18q ...

Alyglo is manufactured using cation exchange chromatography, which reduces coagulation factor XIa to undetectable levels. Alyglo ™ (immune globulin intravenous, human-stwk) 10% liquid is now available ...

Please provide your email address to receive an email when new articles are posted on . 23.5% of patients with an IgE deficiency had a malignancy diagnosis. Nonatopic patients were more likely to have ...